<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34145375</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>18</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice.</ArticleTitle><Pagination><StartPage>12890</StartPage><MedlinePgn>12890</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12890</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-92369-8</ELocationID><Abstract><AbstractText>Degeneration and death of motor neurons in Amyotrophic Lateral Sclerosis (ALS) are associated with increased lipid peroxidation. Lipid peroxidation is the driver of ferroptosis, an iron-dependent oxidative mode of cell death. However, the importance of ferroptosis in motor neuron degeneration of ALS remains unclear. Glutathione peroxidase 4 (Gpx4) is a key enzyme in suppressing ferroptosis by reducing phospholipid hydroperoxides in membranes. To assess the effect of increased protection against ferroptosis on motor neuron disease, we generated SOD1<sup>G93A</sup>GPX4 double transgenic mice by cross-breeding GPX4 transgenic mice with SOD1<sup>G93A</sup> mice, a widely used ALS mouse model. Compared with control SOD1<sup>G93A</sup> mice, both male and female SOD1<sup>G93A</sup>GPX4 mice had extended lifespans. SOD1<sup>G93A</sup>GPX4 mice also showed delayed disease onset and increased motor function, which were correlated with ameliorated spinal motor neuron degeneration and reduced lipid peroxidation. Moreover, cell toxicity induced by SOD1<sup>G93A</sup> was ameliorated by Gpx4 overexpression and by chemical inhibitors of ferroptosis in vitro. We further found that the anti-ferroptosis defense system in spinal cord tissues of symptomatic SOD1<sup>G93A</sup> mice and sporadic ALS patients might be compromised due to deficiency of Gpx4. Thus, our results suggest that ferroptosis plays a key role in motor neuron degeneration of ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Liuji</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cell Systems &amp; Anatomy, University of Texas Health San Antonio, 7703 Floyd Curl Dr., San Antonio, TX, 78229, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Na</LastName><ForeName>Ren</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cell Systems &amp; Anatomy, University of Texas Health San Antonio, 7703 Floyd Curl Dr., San Antonio, TX, 78229, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danae McLane</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cell Systems &amp; Anatomy, University of Texas Health San Antonio, 7703 Floyd Curl Dr., San Antonio, TX, 78229, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Cody Sylvester</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Cell Systems &amp; Anatomy, University of Texas Health San Antonio, 7703 Floyd Curl Dr., San Antonio, TX, 78229, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Ju</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Experimental Neurosciences, University of Nebraska Medical Center, Omaha, NE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xinglong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Experimental Neurosciences, University of Nebraska Medical Center, Omaha, NE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ran</LastName><ForeName>Qitao</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Cell Systems &amp; Anatomy, University of Texas Health San Antonio, 7703 Floyd Curl Dr., San Antonio, TX, 78229, USA. ran@uthscsa.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Service, South Texas Veterans Health Care System, San Antonio, TX, USA. ran@uthscsa.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 BX003507</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG064078</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG064078</GrantID><Agency>NIA, NIH</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.11.1.12</RegistryNumber><NameOfSubstance UI="D000080662">Phospholipid Hydroperoxide Glutathione Peroxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.11.1.9</RegistryNumber><NameOfSubstance UI="C000611332">glutathione peroxidase 4, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079403" MajorTopicYN="N">Ferroptosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="Y">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008136" MajorTopicYN="N">Longevity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="N">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000080662" MajorTopicYN="N">Phospholipid Hydroperoxide Glutathione Peroxidase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34145375</ArticleId><ArticleId IdType="pmc">PMC8213805</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-92369-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-92369-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan MC, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsultan AA, Waller R, Heath PR, Kirby J. The genetics of amyotrophic lateral sclerosis: Current insights. Degener. Neurol. Neuromuscul. Dis. 2016;6:49&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6053097</ArticleId><ArticleId IdType="pubmed">30050368</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2011;7:616&#x2013;630. doi: 10.1038/nrneurol.2011.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, et al. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph. Lateral. Scler. Frontotemporal. Degener. 2013;14(Suppl 1):19&#x2013;32. doi: 10.3109/21678421.2013.778554.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.778554</ArticleId><ArticleId IdType="pmc">PMC4284067</ArticleId><ArticleId IdType="pubmed">23678877</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: Disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D, Mansfield C, Moussy A, Hermine O. ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Front. Aging Neurosci. 2017;9:68. doi: 10.3389/fnagi.2017.00068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00068</ArticleId><ArticleId IdType="pmc">PMC5360725</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId></ArticleIdList></Reference><Reference><Citation>Perluigi M, et al. Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice&#x2013;a model of familial amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2005;38:960&#x2013;968. doi: 10.1016/j.freeradbiomed.2004.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2004.12.021</ArticleId><ArticleId IdType="pubmed">15749392</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H, et al. Oxidative stress biomarkers in sporadic ALS. Amyotroph. Lateral. Scler. 2008;9:177&#x2013;183. doi: 10.1080/17482960801933942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960801933942</ArticleId><ArticleId IdType="pmc">PMC4332387</ArticleId><ArticleId IdType="pubmed">18574762</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon SJ, et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060&#x2013;1072. doi: 10.1016/j.cell.2012.03.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.03.042</ArticleId><ArticleId IdType="pmc">PMC3367386</ArticleId><ArticleId IdType="pubmed">22632970</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang WS, Stockwell BR. Ferroptosis: Death by lipid peroxidation. Trends Cell Biol. 2016;26:165&#x2013;176. doi: 10.1016/j.tcb.2015.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2015.10.014</ArticleId><ArticleId IdType="pmc">PMC4764384</ArticleId><ArticleId IdType="pubmed">26653790</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockwell BR, et al. Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273&#x2013;285. doi: 10.1016/j.cell.2017.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.09.021</ArticleId><ArticleId IdType="pmc">PMC5685180</ArticleId><ArticleId IdType="pubmed">28985560</ArticleId></ArticleIdList></Reference><Reference><Citation>Brigelius-Flohe R. Tissue-specific functions of individual glutathione peroxidases. Free Radic. Biol. Med. 1999;27:951&#x2013;965. doi: 10.1016/S0891-5849(99)00173-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(99)00173-2</ArticleId><ArticleId IdType="pubmed">10569628</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang WS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317&#x2013;331. doi: 10.1016/j.cell.2013.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.12.010</ArticleId><ArticleId IdType="pmc">PMC4076414</ArticleId><ArticleId IdType="pubmed">24439385</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Hambright WS, Na R, Ran Q. Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis. J. Biol. Chem. 2015;290:28097&#x2013;28106. doi: 10.1074/jbc.M115.680090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.680090</ArticleId><ArticleId IdType="pmc">PMC4653669</ArticleId><ArticleId IdType="pubmed">26400084</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, et al. Motor neuron degeneration in mice that express a human Cu Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran Q, et al. Transgenic mice overexpressing glutathione peroxidase 4 are protected against oxidative stress-induced apoptosis. J. Biol. Chem. 2004;279:55137&#x2013;55146. doi: 10.1074/jbc.M410387200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M410387200</ArticleId><ArticleId IdType="pubmed">15496407</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran Q, et al. Glutathione peroxidase 4 protects cortical neurons from oxidative injury and amyloid toxicity. J. Neurosci. Res. 2006;84:202&#x2013;208. doi: 10.1002/jnr.20868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.20868</ArticleId><ArticleId IdType="pubmed">16673405</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitner, M., Menzies, S. &amp; Lutz, C. in The Jackson Laboratory (2009).</Citation></Reference><Reference><Citation>Stevens JC, et al. Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag&#x2013;implications for research into amyotrophic lateral sclerosis (ALS) PLoS ONE. 2010;5:e9541. doi: 10.1371/journal.pone.0009541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009541</ArticleId><ArticleId IdType="pmc">PMC2833207</ArticleId><ArticleId IdType="pubmed">20221404</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilka O, et al. On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent Sci. 2017;3:232&#x2013;243. doi: 10.1021/acscentsci.7b00028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.7b00028</ArticleId><ArticleId IdType="pmc">PMC5364454</ArticleId><ArticleId IdType="pubmed">28386601</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedmann Angeli JP, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 2014;16:1180&#x2013;1191. doi: 10.1038/ncb3064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb3064</ArticleId><ArticleId IdType="pmc">PMC4894846</ArticleId><ArticleId IdType="pubmed">25402683</ArticleId></ArticleIdList></Reference><Reference><Citation>Foust KD, et al. Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS. Mol. Ther. 2013;21:2148&#x2013;2159. doi: 10.1038/mt.2013.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2013.211</ArticleId><ArticleId IdType="pmc">PMC3863799</ArticleId><ArticleId IdType="pubmed">24008656</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zundert B, Brown RH., Jr Silencing strategies for therapy of SOD1-mediated ALS. Neurosci. Lett. 2017;636:32&#x2013;39. doi: 10.1016/j.neulet.2016.07.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.07.059</ArticleId><ArticleId IdType="pubmed">27507699</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilton JB, et al. Cu(II)(atsm) improves the neurological phenotype and survival of SOD1(G93A) mice and selectively increases enzymatically active SOD1 in the spinal cord. Sci. Rep. 2017;7:42292. doi: 10.1038/srep42292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42292</ArticleId><ArticleId IdType="pmc">PMC5304223</ArticleId><ArticleId IdType="pubmed">28205575</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson EP, Henry YK, Henkel JS, Smith RG, Appel SH. Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden. Neurology. 2004;62:1758&#x2013;1765. doi: 10.1212/WNL.62.10.1758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.62.10.1758</ArticleId><ArticleId IdType="pubmed">15159474</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen WA, et al. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann. Neurol. 1998;44:819&#x2013;824. doi: 10.1002/ana.410440518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410440518</ArticleId><ArticleId IdType="pubmed">9818940</ArticleId></ArticleIdList></Reference><Reference><Citation>Devos D, et al. A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis. Sci. Rep. 2019;9:2918. doi: 10.1038/s41598-019-39739-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39739-5</ArticleId><ArticleId IdType="pmc">PMC6393674</ArticleId><ArticleId IdType="pubmed">30814647</ArticleId></ArticleIdList></Reference><Reference><Citation>Spasi&#x107; S, et al. Edaravone may prevent ferroptosis in ALS. Curr. Drug Targets. 2020;21:776&#x2013;780. doi: 10.2174/1389450121666200220123305.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389450121666200220123305</ArticleId><ArticleId IdType="pubmed">32077821</ArticleId></ArticleIdList></Reference><Reference><Citation>Homma T, Kobayashi S, Sato H, Fujii J. Edaravone, a free radical scavenger, protects against ferroptotic cell death in vitro. Exp. Cell Res. 2019;384:111592. doi: 10.1016/j.yexcr.2019.111592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2019.111592</ArticleId><ArticleId IdType="pubmed">31479686</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, et al. Prevention of motor neuron degeneration by novel iron chelators in SOD1(G93A) transgenic mice of amyotrophic lateral sclerosis. Neurodegener. Dis. 2011;8:310&#x2013;321. doi: 10.1159/000323469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000323469</ArticleId><ArticleId IdType="pubmed">21346313</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupershmidt L, et al. Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis. FASEB J. 2009;23:3766&#x2013;3779. doi: 10.1096/fj.09-130047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.09-130047</ArticleId><ArticleId IdType="pubmed">19638399</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas MR, Johnson DA, Johnson JA. Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1(G93A) mice model. Neurobiol. Dis. 2011;43:543&#x2013;551. doi: 10.1016/j.nbd.2011.04.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.04.025</ArticleId><ArticleId IdType="pmc">PMC3139005</ArticleId><ArticleId IdType="pubmed">21600285</ArticleId></ArticleIdList></Reference><Reference><Citation>Brigelius-Flohe R, Maiorino M. Glutathione peroxidases. Biochim. Biophys. Acta. 2013;1830:3289&#x2013;3303. doi: 10.1016/j.bbagen.2012.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2012.11.020</ArticleId><ArticleId IdType="pubmed">23201771</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz ME, et al. Survival in transgenic ALS mice does not vary with CNS glutathione peroxidase activity. Neurology. 2002;59:729&#x2013;734. doi: 10.1212/WNL.59.5.729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.59.5.729</ArticleId><ArticleId IdType="pubmed">12221165</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari A, Xu Z, Hayward LJ. Aberrantly increased hydrophobicity shared by mutants of Cu, Zn-superoxide dismutase in familial amyotrophic lateral sclerosis. J. Biol. Chem. 2005;280:29771&#x2013;29779. doi: 10.1074/jbc.M504039200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M504039200</ArticleId><ArticleId IdType="pubmed">15958382</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science. 2000;288:335&#x2013;339. doi: 10.1126/science.288.5464.335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.288.5464.335</ArticleId><ArticleId IdType="pubmed">10764647</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli, P., Houseweart, M.K., Brown, R.H., &amp; Cleveland, D.W. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A97, 13901&#x2013;13906 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC17673</ArticleId><ArticleId IdType="pubmed">11095709</ArticleId></ArticleIdList></Reference><Reference><Citation>Guegan C, Przedborski S. Programmed cell death in amyotrophic lateral sclerosis. J. Clin. Invest. 2003;111:153&#x2013;161. doi: 10.1172/JCI200317610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI200317610</ArticleId><ArticleId IdType="pmc">PMC151885</ArticleId><ArticleId IdType="pubmed">12531867</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, et al. Chaperone-mediated autophagy is involved in the execution of ferroptosis. Proc Natl Acad Sci U S A. 2019;116:2996&#x2013;3005. doi: 10.1073/pnas.1819728116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1819728116</ArticleId><ArticleId IdType="pmc">PMC6386716</ArticleId><ArticleId IdType="pubmed">30718432</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto N, et al. Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res. 2007;1167:112&#x2013;117. doi: 10.1016/j.brainres.2007.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2007.06.045</ArticleId><ArticleId IdType="pubmed">17689501</ArticleId></ArticleIdList></Reference><Reference><Citation>An T, et al. Oxidative stress and autophagic alteration in brainstem of SOD1-G93A mouse model of ALS. Mol. Neurobiol. 2014;49:1435&#x2013;1448. doi: 10.1007/s12035-013-8623-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8623-3</ArticleId><ArticleId IdType="pubmed">24390572</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott S, et al. Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph. Lateral Scler. 2008;9:4&#x2013;15. doi: 10.1080/17482960701856300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701856300</ArticleId><ArticleId IdType="pubmed">18273714</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, et al. Reduction of mitochondrial H2O2 by overexpressing peroxiredoxin 3 improves glucose tolerance in mice. Aging Cell. 2008;7:866&#x2013;878. doi: 10.1111/j.1474-9726.2008.00432.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1474-9726.2008.00432.x</ArticleId><ArticleId IdType="pmc">PMC4431549</ArticleId><ArticleId IdType="pubmed">18778410</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiorino M, et al. Phospholipid hydroperoxide glutathione peroxidase is the 18-kDa selenoprotein expressed in human tumor cell lines. J. Biol. Chem. 1991;266:7728&#x2013;7732. doi: 10.1016/S0021-9258(20)89509-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(20)89509-X</ArticleId><ArticleId IdType="pubmed">2019596</ArticleId></ArticleIdList></Reference><Reference><Citation>Hambright WS, Fonseca RS, Chen L, Na R, Ran Q. Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration. Redox. Biol. 2017;12:8&#x2013;17. doi: 10.1016/j.redox.2017.01.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2017.01.021</ArticleId><ArticleId IdType="pmc">PMC5312549</ArticleId><ArticleId IdType="pubmed">28212525</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>